share_log

Craig-Hallum Assumes DiaMedica Therapeutics at Buy, Announces Price Target of $8

Moomoo 24/7 ·  Apr 24 13:33

Craig-Hallum analyst Alexander Nowak assumes DiaMedica Therapeutics (NASDAQ:DMAC) with a Buy rating and announces Price Target of $8.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment